Task: Answer the multiple choice question.
Question: Which drug exhibits a -64.908% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CC1CCCCN1CCCNC(=O)c1cc(Br)c(Br)[nH]1
b) CC1CC(C)CN(S(=O)(=O)c2ccc3c(c2)oc(=O)n3CC(=O)N(C)Cc2ccccc2)C1
Answer: a. CC1CCCCN1CCCNC(=O)c1cc(Br)c(Br)[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCCCN1CCCNC(=O)c1cc(Br)c(Br)[nH]1
CC1CCCCN1CCCNC(=O)c1cc(Br)c(Br)[nH]1
4,5-dibromo-N-[3-(2-methylpiperidin-1-yl)propyl]-1H-pyrrole-2-carboxamide